Skip to Content

Join the 'Aspirin / omeprazole' group to help and get support from people like you.

Aspirin / omeprazole News

Wider Low-Dose Aspirin Use Would Save U.S. $692 Billion: Study

Posted 7 days ago by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Taking low-dose aspirin daily can reduce older Americans' risk of heart disease and cancer, and lead to significant savings in health care spending, a new study contends. University of Southern California researchers used national data to assess the long-term benefits of daily aspirin usage. They calculated that taking low-dose aspirin every day would prevent 11 cases of heart disease and four cases of cancer for every 1,000 Americans ages 51 to 79. "Although the health benefits of aspirin are well-established, few people take it," said study lead author Dr. David Agus. He's the founding director and CEO of the university's Lawrence J. Ellison Institute for Transformative Medicine. "Our study shows multiple health benefits and a reduction in health care spending from this simple, low-cost measure that should be considered a standard part of care for the ... Read more

Related support groups: Aspirin, Ischemic Stroke, Excedrin, Transient Ischemic Attack, Aggrenox, Alka-Seltzer, Fiorinal, Excedrin Migraine, Prevention of Cardiovascular Disease, Ecotrin, Ischemic Stroke - Prophylaxis, Fiorinal with Codeine, Arthritis Pain, Arthritis Pain Formula, Bayer Aspirin, Soma Compound, Cardiovascular Risk Reduction, Norgesic, Excedrin Extra Strength, Norgesic Forte

Could Common Heartburn Drugs Up Stroke Risk?

Posted 15 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – A popular category of heartburn medications – including Nexium, Prevacid, Prilosec and Protonix – may increase your risk of stroke, a new study suggests. Known as proton pump inhibitors (PPIs), these drugs increased people's overall stroke risk by 21 percent, said study lead author Dr. Thomas Sehested. However, the risk appears to be driven by people who take high doses, added Sehested, research director at the Danish Heart Foundation in Copenhagen. "People treated with a low dose of PPIs did not have a high risk of stroke," he said. "Those treated with the highest doses of PPIs had the highest risk of stroke." The extent of risk also depends on the specific PPI taken. At the highest dose, stroke risk ranged from 30 percent for lansoprazole (Prevacid) to 94 percent for pantoprazole (Protonix), the researchers said. Takeda Pharmaceutical, the maker of ... Read more

Related support groups: GERD, Heart Disease, Ischemic Stroke, Omeprazole, Nexium, Dementia, Prilosec, Zantac, Protonix, Indigestion, Alzheimer's Disease, Pantoprazole, Ranitidine, Lansoprazole, Dexilant, Prevacid, Transient Ischemic Attack, Pepcid, Barrett's Esophagus, Aciphex

Take Meds as Directed to Boost Survival After Heart Procedures

Posted 24 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Taking medications as prescribed improves outcomes for heart procedure patients, a new study finds. Researchers looked at 973 heart bypass patients and 2,255 patients who underwent angioplasty and stenting to reopen clogged heart arteries. Heart bypass surgery is when surgeons take a piece of blood vessel from somewhere else in the body to bypass a blocked portion of the heart's artery. Angioplasty is performed using a thin catheter that's threaded through the blood vessels to the heart. A balloon on the end of the catheter is inflated to open the narrowed blood vessel. Sometimes a stent (a mesh or wire tube) will be left in the blood vessel to keep it open. Prescribed medications in the study included cholesterol-lowering statins, blood thinners and beta blockers. Follow-up information was collected 12 to 18 months after the heart procedures. Overall, ... Read more

Related support groups: Surgery, Aspirin, Metoprolol, Atenolol, Lipitor, Propranolol, Simvastatin, Crestor, Bystolic, Atorvastatin, Pravastatin, Carvedilol, Bisoprolol, Excedrin, Coreg, Inderal, Sotalol, Zocor, Lovastatin, Toprol-XL

FDA Approves Yosprala (aspirin and omeprazole) for Secondary Prevention of Cardiovascular Disease in Patients at Risk for Aspirin-Associated Gastric Ulcers

Posted 16 Sep 2016 by Drugs.com

MISSISSAUGA, Ontario, Sept. 15, 2016 /PRNewswire/ – Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved once-daily Yosprala, the only prescription fixed-dose combination of aspirin, an anti-platelet agent, and omeprazole, a proton pump inhibitor (PPI) in the U.S. Yosprala is indicated for patients who require aspirin for secondary prevention of cardiovascular (CV) and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. The Company is expanding its U.S. sales force by 85 representatives in September to a total of 110 high quality sales representatives and plans to begin the U.S. promotional launch of Yosprala the first week in October. "Daily aspirin is a standard of care for secondary cardiovascular event prevention, but ... Read more

Related support groups: Aspirin, Omeprazole, Prevention of Cardiovascular Disease, Yosprala, NSAID-Induced Ulcer Prophylaxis, Gastric Ulcer Prophylaxis, Aspirin/omeprazole

Ask a Question

Further Information

Related Condition Support Groups

Prevention of Cardiovascular Disease

Related Drug Support Groups

Yosprala

Aspirin / omeprazole Patient Information at Drugs.com